Current Rheumatology Reports

, Volume 6, Issue 1, pp 70–78

Bone disease in pediatric rheumatologic disorders

  • Jon M. Burnham
  • Mary B. Leonard
Article

Abstract

Children with rheumatic disorders have multiple risk factors for impaired bone health, including delayed growth and development, malnutrition, decreased weight-bearing activity, inflammation, and glucocorticoid therapy. The impact of rheumatic disease during childhood may be immediate, resulting in fragility fractures, or delayed, because of suboptimal peak bone mass accrual. Recent years have seen increased interest in the effects of pediatric rheumatic disorders on bone mineralization, such as juvenile rheumatoid arthritis, systemic lupus erythematosus, and juvenile dermatomyositis. This review outlines the expected gains in bone size and mass during childhood and adolescence, and summarizes the advantages and disadvantages of available technologies for the assessment of skeletal growth and fragility in children. The varied threats to bone health in pediatric rheumatic disorders are reviewed, with emphasis on recent insights into the molecular mechanisms of inflammation-induced bone resorption. The literature assessing bone deficits and risk factors for impaired bone health in pediatric rheumatic disorders is reviewed, with consideration of the strengths and limitations of prior studies. Finally, future research directions are proposed.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Bailey DA, McKay HA, Mirwald RL, et al.: A six-year longitudinal study of the relationship of physical activity to bone mineral accrual in growing children: the University of Saskatchewan bone mineral accrual study. J Bone Miner Res 1999, 14:1672–1679.PubMedCrossRefGoogle Scholar
  2. 2.
    National Institutes of Health: Osteoporosis prevention, diagnosis, and therapy. NIH Consensus Statement 2000, 17:1–36.Google Scholar
  3. 3.
    Schoenau E, Neu CM, Rauch F, Manz F: The development of bone strength at the proximal radius during childhood and adolescence. J Clin Endocrinol Metab 2001, 86:613–618.PubMedCrossRefGoogle Scholar
  4. 4.
    Gilsanz V, Kovanlikaya A, Costin G, et al.: Differential effect of gender on the sizes of the bones in the axial and appendicular skeletons. J Clin Endocrinol Metab 1997, 82:1603–1607.PubMedCrossRefGoogle Scholar
  5. 5.
    Gilsanz V, Skaggs DL, Kovanlikaya A, et al.: Differential effect of race on the axial and appendicular skeletons of children. J Clin Endocrinol Metab 1998, 83:1420–1427.PubMedCrossRefGoogle Scholar
  6. 6.
    Parfitt AM: The two faces of growth: benefits and risks to bone integrity. Osteoporos Int 1994, 4:382–398.PubMedCrossRefGoogle Scholar
  7. 7.
    Hangartner TN, Gilsanz V: Evaluation of cortical bone by computed tomography. J Bone Miner Res 1996, 11:1518–1525.PubMedGoogle Scholar
  8. 8.
    Lum CK, Wang MC, Moore E, et al.: A comparison of calcaneus ultrasound and dual x-ray absorptiometry in healthy North American youths and young adults. J Clin Densitom 1999, 2:403–411.PubMedCrossRefGoogle Scholar
  9. 9.
    Falcini F, Bindi G, Ermini M, et al.: Comparison of quantitative calcaneal ultrasound and dual energy x-ray absorptiometry in the evaluation of osteoporotic risk in children with chronic rheumatic diseases. Calcif Tissue Int 2000, 67:19–23.PubMedCrossRefGoogle Scholar
  10. 10.
    The WHO Study Group: Asessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis. Geneva, Switzerland: World Health Organization; 1994.Google Scholar
  11. 11.
    Khosla S, Melton LJ, III, Dekutoski MB, et al.: Incidence of childhood distal forearm fractures over 30 years: a population-based study. JAMA 2003, 290:1479–1485.PubMedCrossRefGoogle Scholar
  12. 12.
    Jones IE, Williams SM, Dow N, Goulding A: How many children remain fracture-free during growth? A longitudinal study of children and adolescents participating in the Dunedin Multidisciplinary Health and Development Study. Osteoporos Int 2002, 13:990–995.PubMedCrossRefGoogle Scholar
  13. 13.
    Goulding A, Jones IE, Taylor RW, et al.: More broken bones: a 4-year double cohort study of young girls with and without distal forearm fractures. J Bone Miner Res 2000, 15:2011–2018.PubMedCrossRefGoogle Scholar
  14. 14.
    Goulding A, Jones IE, Taylor RW, et al.: Bone mineral density and body composition in boys with distal forearm fractures: a dual-energy x-ray absorptiometry study. J Pediatr 2001, 139:509–515.PubMedCrossRefGoogle Scholar
  15. 15.
    Ma DQ, Jones G: Clinical risk factors but not bone density are associated with prevalent fractures in prepubertal children. J Paediatr Child Health 2002, 38:497–500.PubMedCrossRefGoogle Scholar
  16. 16.
    Skaggs DL, Loro ML, Pitukcheewanont P, et al.: Increased body weight and decreased radial cross-sectional dimensions in girls with forearm fractures. J Bone Miner Res 2001, 16:1337–1342. Using pQCT, the authors demonstrated the association of diminished cross-sectional area in the distal radius, compared with controls, in a group of girls who sustained forearm fractures. This study illustrates the fundamental relationship between bone geometry and bone strength.PubMedCrossRefGoogle Scholar
  17. 17.
    Carter DR, Bouxsein ML, Marcus R: New approaches for interpreting projected bone densitometry data. J Bone Miner Res 1992, 7:137–145.PubMedCrossRefGoogle Scholar
  18. 18.
    Ma D, Jones G: The Association between bone mineral density, metacarpal morphometry, and upper limb fractures in children: a population-based case-control study. J Clin Endocrinol Metab 2003, 88:1486–1491.PubMedCrossRefGoogle Scholar
  19. 19.
    Molgaard C, Thomsen BL, Prentice A, et al.: Whole body bone mineral content in healthy children and adolescents. Arch Dis Child 1997, 76:9–15.PubMedGoogle Scholar
  20. 20.
    Ellis KJ, Shypailo RJ, Hardin DS, et al.: Z score prediction model for assessment of bone mineral content in pediatric diseases. J Bone Miner Res 2001, 16:1658–1664.PubMedCrossRefGoogle Scholar
  21. 21.
    Goulding A, Taylor RW, Jones IE, et al.: Overweight and obese children have low bone mass and area for their weight. Int J Obes Relat Metab Disord 2000, 24:627–632.PubMedCrossRefGoogle Scholar
  22. 22.
    Leonard MB, Shults J, Elliot DM, et al.: Assessment of cortical bone mineralization using whole body DXA: validation with peripheral quantitative computed tomography. Bone 2003, in press.Google Scholar
  23. 23.
    Southard RN, Morris JD, Mahan JD, et al.: Bone mass in healthy children: measurement with quantitative DXA. Radiology 1991, 179:735–738.PubMedGoogle Scholar
  24. 24.
    Faulkner RA, Bailey DA, Drinkwater DT, et al.: Bone densitometry in Canadian children 8–17 years of age. Calcif Tissue Int 1996, 59:344–351.PubMedCrossRefGoogle Scholar
  25. 25.
    Plotkin H, Nunez M, Alvarez-Filgueira ML, Zanchetta JR: Lumbar spine bone density in Argentine children. Calcif Tissue Int 1996, 58:144–149.PubMedGoogle Scholar
  26. 26.
    Bonjour JP, Theintz G, Buchs B, et al.: Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab 1991, 73:555–563.PubMedCrossRefGoogle Scholar
  27. 27.
    Glastre C, Braillon P, David L, et al.: Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters. J Clin Endocrinol Metab 1990, 70:1330–1333.PubMedGoogle Scholar
  28. 28.
    Ellis KJ, Shypailo RJ, Wong WW, Abrams SA: Prediction models for bone mineral content in school-aged children. Ann N Y Acad Sci 2000, 904:428–432.PubMedCrossRefGoogle Scholar
  29. 29.
    Binkley TL, Specker BL, Wittig TA: Centile curves for bone densitometry measurements in healthy males and females ages 5 to 22 years. J Clin Densitom 2002, 5:343–353.PubMedCrossRefGoogle Scholar
  30. 30.
    Hannan WJ, Tothill P, Cowen SJ, Wrate RM: Whole body bone mineral content in healthy children and adolescents. Arch Dis Child 1998, 78:396–397.PubMedCrossRefGoogle Scholar
  31. 31.
    Maynard LM, Guo SS, Chumlea WC, et al.: Total-body and regional bone mineral content and areal bone mineral density in children aged 8 to 18 years: the Fels Longitudinal Study. Am J Clin Nutr 1998, 68:1111–1117.PubMedGoogle Scholar
  32. 32.
    van der Sluis IM, de Ridder MA, Boot AM, et al.: Reference data for bone density and body composition measured with dual energy x-ray absorptiometry in white children and young adults. Arch Dis Child 2002, 87:341–347.PubMedCrossRefGoogle Scholar
  33. 33.
    Leonard MB, Propert KJ, Zemel BS, et al.: Discrepancies in pediatric bone mineral density reference data: potential for misdiagnosis of osteopenia. J Pediatr 1999, 135:182–188. The authors analyzed bone density in a group of children with chronic diseases using different reference data sets. They found significant discrepancies in z scores depending on the reference data that were utilized. A substantial potential for misdiagnosis of osteopenia was evident, and was most pronounced in peripubertal boys when gendernonspecific reference data were used.PubMedCrossRefGoogle Scholar
  34. 34.
    Khosla S: Mini-review: the OPG/RANKL/RANK system. Endocrinology 2001, 142:5050–5055.PubMedCrossRefGoogle Scholar
  35. 35.
    Bolon B, Shalhoub V, Kostenuik PJ, et al.: Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis. Arthritis Rheum 2002, 46:3121–3135. An outstanding review of the basic science of the OPG/RANKL/RANK system, with a focus on the potential for therapeutic intervention in RA.PubMedCrossRefGoogle Scholar
  36. 36.
    Bromley SK, Dustin ML: Stimulation of naive T-cell adhesion and immunological synapse formation by chemokinedependent and -independent mechanisms. Immunology 2002, 106:289–298.PubMedCrossRefGoogle Scholar
  37. 37.
    Gravallese EM: Bone destruction in arthritis. Ann Rheum Dis 2002, 61(suppl):84–86.Google Scholar
  38. 38.
    Varsani H, Patel A, van Kooyk Y, et al.: Synovial dendritic cells in juvenile idiopathic arthritis (JIA) express receptor activator of NF-kappaB (RANK). Rheumatology (Oxford) 2003, 42:583–590.Google Scholar
  39. 39.
    Ziolkowska M, Kurowska M, Radzikowska A, et al.: High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment. Arthritis Rheum 2002, 46:1744–1753.PubMedCrossRefGoogle Scholar
  40. 40.
    Lien G, Flato B, Haugen M, et al.: Frequency of osteopenia in adolescents with early-onset juvenile idiopathic arthritis: a long-term outcome study of one hundred five patients. Arthritis Rheum 2003, 48:2214–2223. A study of 105 juvenile idiopathic arthritis patients, which found deficits in whole body, spine, and femoral neck sites using DXA.PubMedCrossRefGoogle Scholar
  41. 41.
    Pepmueller PH, Cassidy JT, Allen SH, Hillman LS: Bone mineralization and bone mineral metabolism in children with juvenile rheumatoid arthritis. Arthritis Rheum 1996, 39:746–757. A study of 41 children and adolescents with JRA using DXA of the whole body, radius, and spine, which found deficits to be the most prominent in patients with polyarticular disease.PubMedCrossRefGoogle Scholar
  42. 42.
    Kotaniemi A, Savolainen A, Kroger H, et al.: Weight-bearing physical activity, calcium intake, systemic glucocorticoids, chronic inflammation, and body constitution as determinants of lumbar and femoral bone mineral in juvenile chronic arthritis. Scand J Rheumatol 1999, 28:19–26. The authors presented an interesting analysis of factors associated with osteopenia in juvenile chronic arthritis, using complex statistical modeling.PubMedCrossRefGoogle Scholar
  43. 43.
    Henderson CJ, Cawkwell GD, Specker BL, et al.: Predictors of total body bone mineral density in non-corticosteroidtreated prepubertal children with juvenile rheumatoid arthritis. Arthritis Rheum 1997, 40:1967–1975. In this study, whole body BMD was examined in 48 prepubertal girls with mild-moderate JRA. The results may have been confounded by age and short stature.PubMedCrossRefGoogle Scholar
  44. 44.
    Knops N, Wulffraat N, Lodder S, et al.: Resting energy expenditure and nutritional status in children with juvenile rheumatoid arthritis. J Rheumatol 1999, 26:2039–2043.PubMedGoogle Scholar
  45. 45.
    Lofthouse CM, Azad F, Baildam EM, Akobeng AK: Measuring the nutritional status of children with juvenile idiopathic arthritis using the bioelectrical impedance method. Rheumatology (Oxford) 2002, 41:1172–1177.CrossRefGoogle Scholar
  46. 46.
    Klepper SE: Exercise and fitness in children with arthritis: evidence of benefits for exercise and physical activity. Arthritis Rheum 2003, 49:435–443.PubMedCrossRefGoogle Scholar
  47. 47.
    Rusconi R, Corona F, Grassi A, Carnelli V: Age at menarche in juvenile rheumatoid arthritis. J Pediatr Endocrinol Metab 2003, 16(suppl):285–288.PubMedGoogle Scholar
  48. 48.
    Anai T, Miyazaki F, Tomiyasu T, Matsuo T: Risk of irregular menstrual cycles and low peak bone mass during early adulthood associated with age at menarche. Pediatr Int 2001, 43:483–488.PubMedCrossRefGoogle Scholar
  49. 49.
    Lane NE, Rehman Q: Osteoporosis in the rheumatic disease patient. Lupus 2002, 11:675–679.PubMedCrossRefGoogle Scholar
  50. 50.
    Perez MD, Abrams SA, Loddeke L, et al.: Effects of rheumatic disease and corticosteroid treatment on calcium metabolism and bone density in children assessed one year after diagnosis, using stable isotopes and dual energy x-ray absorptiometry. J Rheumatol 2000, 27(suppl):38–43.Google Scholar
  51. 51.
    Stewart WA, Acott PD, Salisbury SR, Lang BA: Bone mineral density in juvenile dermatomyositis: assessment using dual x-ray absorptiometry. Arthritis Rheum 2003, 48:2294–2298.PubMedCrossRefGoogle Scholar
  52. 52.
    Njeh CF, Shaw N, Gardner-Medwin JM, et al.: Use of quantitative ultrasound to assess bone status in children with juvenile idiopathic arthritis: a pilot study. J Clin Densitom 2000, 3:251–260. A small study of 22 juvenile idiopathic arthritis patients using DXA of the whole body and spine. DXA results may have been confounded by short stature.PubMedCrossRefGoogle Scholar
  53. 53.
    Kotaniemi A, Savolainen A, Kautiainen H, Kroger H: Estimation of central osteopenia in children with chronic polyarthritis treated with glucocorticoids. Pediatrics 1993, 91:1127–1130. The authors studied DXA BMD and BMAD of the spine and hip using DXA in 43 girls with polyarticular arthritis. The use of BMAD helped to control for short stature in the patient group.PubMedGoogle Scholar
  54. 54.
    Henderson CJ, Specker BL, Sierra RI, et al.: Total-body bone mineral content in non-corticosteroid-treated postpubertal females with juvenile rheumatoid arthritis: frequency of osteopenia and contributing factors. Arthritis Rheum 2000, 43:531–540.PubMedCrossRefGoogle Scholar
  55. 55.
    Pereira RM, Corrente JE, Chahade WH, Yoshinari NH: Evaluation by dual x-ray absorptiometry (DXA) of bone mineral density in children with juvenile chronic arthritis. Clin Exp Rheumatol 1998, 16:495–501. The authors studied 62 children and adolescents with juvenile chronic arthritis. Gender-specific z scores and statistical models that controlled for height and weight strengthen the results.PubMedGoogle Scholar
  56. 56.
    Schoenau E, Neu CM, Beck B, et al.: Bone mineral content per muscle cross-sectional area as an index of the functional muscle-bone unit. J Bone Miner Res 2002, 17:1095–1101.PubMedCrossRefGoogle Scholar
  57. 57.
    French AR, Mason T, Nelson AM, et al.: Osteopenia in adults with a history of juvenile rheumatoid arthritis: a population based study. J Rheumatol 2002, 29:1065–1070.PubMedGoogle Scholar
  58. 58.
    Zak M, Hassager C, Lovell DJ, et al.: Assessment of bone mineral density in adults with a history of juvenile chronic arthritis: a cross-sectional long-term follow-up study. Arthritis Rheum 1999, 42:790–798.PubMedCrossRefGoogle Scholar
  59. 59.
    Amin S, Lavalley MP, Simms RW, Felson DT: The comparative efficacy of drug therapies used for the management of corticosteroid-induced osteoporosis: a meta-regression. J Bone Miner Res 2002, 17:1512–1526.PubMedCrossRefGoogle Scholar
  60. 60.
    Buckley LM, Leib ES, Cartularo KS, et al.: Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis: a randomized, double-blind, placebocontrolled trial. Ann Intern Med 1996, 17:961–968.Google Scholar
  61. 61.
    Dibba B, Prentice A, Ceesay M, et al.: Bone mineral contents and plasma osteocalcin concentrations of Gambian children 12 and 24 mo after the withdrawal of a calcium supplement. Am J Clin Nutr 2002, 17:681–686.Google Scholar
  62. 62.
    Johnston CC, Jr., Miller JZ, Slemenda CW, et al.: Calcium supplementation and increases in bone mineral density in children. N Engl J Med 1992, 327:82–87.PubMedCrossRefGoogle Scholar
  63. 63.
    Chan GM, Hoffman K, McMurry M: Effects of dairy products on bone and body composition in pubertal girls. J Pediatr 1995, 126:551–556.PubMedCrossRefGoogle Scholar
  64. 64.
    Lloyd T, Andon MB, Rollings N, et al.: Calcium supplementation and bone mineral density in adolescent girls. JAMA 1993, 270:841–844.PubMedCrossRefGoogle Scholar
  65. 65.
    Wang MC, Crawford PB, Hudes M, et al.: Diet in midpuberty and sedentary activity in prepuberty predict peak bone mass. Am J Clin Nutr 2003, 77:495–503.PubMedGoogle Scholar
  66. 66.
    Specker B, Binkley T: Randomized trial of physical activity and calcium supplementation on bone mineral content in 3- to 5-year-old children. J Bone Miner Res 2003, 18:885–892.PubMedCrossRefGoogle Scholar
  67. 67.
    Docio S, Riancho JA, Perez A, et al.: Seasonal deficiency of vitamin D in children: a potential target for osteoporosispreventing strategies? J Bone Miner Res 1998, 13:544–548.PubMedCrossRefGoogle Scholar
  68. 68.
    Adachi JD, Saag KG, Delmas PD, et al.: Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, doubleblind, placebo-controlled extension trial. Arthritis Rheum 2001, 44:202–211.PubMedCrossRefGoogle Scholar
  69. 69.
    Saag KG, Emkey R, Schnitzer TJ, et al.: Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med 1998, 339:292–299.PubMedCrossRefGoogle Scholar
  70. 70.
    Glorieux FH, Bishop NJ, Plotkin H, et al.: Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 1998, 339:947–952.PubMedCrossRefGoogle Scholar
  71. 71.
    Zeitlin L, Rauch F, Plotkin H, Glorieux FH: Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV. Pediatrics 2003, 111:1030–1036.PubMedCrossRefGoogle Scholar
  72. 72.
    Rauch F, Travers R, Plotkin H, Glorieux FH: The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Invest 2002, 110:1293–1299.PubMedCrossRefGoogle Scholar
  73. 73.
    Montpetit K, Plotkin H, Rauch F,et al.: Rapid increase in grip force after start of pamidronate therapy in children and adolescents with severe osteogenesis imperfecta. Pediatrics 2003, 111:601–603.CrossRefGoogle Scholar
  74. 74.
    Bianchi ML, Cimaz R, Bardare M, et al.: Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study. Arthritis Rheum 2000, 43:1960–1966.PubMedCrossRefGoogle Scholar
  75. 75.
    Whyte MP, Wenkert D, Clements KL, et al.: Bisphosphonateinduced osteopetrosis. N Engl J Med 2003, 349:457–463.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2004

Authors and Affiliations

  • Jon M. Burnham
  • Mary B. Leonard
    • 1
  1. 1.Department of PediatricsThe Children’s Hospital of PhiladelphiaPhiladelphiaUSA

Personalised recommendations